04429471 1.4.13 31.3.14 31.3.14 Company accounts Private Limited Company FY true false true false true false false Ordinary 0.01000 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure044294712013-03-31044294712014-03-31044294712013-04-012014-03-31044294712012-03-31044294712012-04-012013-03-31044294712013-03-3104429471ns12:England2013-04-012014-03-3104429471ns14:PoundSterling2013-04-012014-03-3104429471ns7:Director12013-04-012014-03-3104429471ns7:OrdinaryShareClass12013-04-012014-03-3104429471ns7:Director22013-04-012014-03-3104429471ns7:Director32013-04-012014-03-3104429471ns7:CompanySecretary2013-04-012014-03-3104429471ns7:RegisteredOffice2013-04-012014-03-3104429471ns7:EntityAccountantsOrAuditors2013-04-012014-03-3104429471ns5:PlantMachinery2013-04-012014-03-3104429471ns5:ComputerEquipment2013-04-012014-03-3104429471ns5:FixedAssetInvestmentsOtherThanLoans2014-03-3104429471ns5:FixedAssetInvestmentsOtherThanLoans2013-03-3104429471ns7:OrdinaryShareClass12014-03-3104429471ns7:OrdinaryShareClass12013-03-31
REGISTERED NUMBER: 04429471 (England and Wales)















ABBREVIATED UNAUDITED ACCOUNTS FOR THE YEAR ENDED 31 MARCH 2014

FOR

BIOINDUCTION LIMITED

BIOINDUCTION LIMITED (REGISTERED NUMBER: 04429471)






CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2014




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

BIOINDUCTION LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2014







DIRECTORS: I S Gillbe
J P Ottaway
N K Patel





SECRETARY: J B M Smith





REGISTERED OFFICE: 178-180 Hotwell Road
Bristol
BS84RP





REGISTERED NUMBER: 04429471 (England and Wales)





ACCOUNTANTS: Lawes & Co
Boyce's Building
40-42 Regent Street
Clifton
Bristol
BS8 4HU

BIOINDUCTION LIMITED (REGISTERED NUMBER: 04429471)

ABBREVIATED BALANCE SHEET
31 MARCH 2014

31.3.14 31.3.13
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 2,596 1,698
Investments 3 55 55
2,651 1,753

CURRENT ASSETS
Stocks 4,512 5,455
Debtors 179,478 177,512
Prepayments and accrued income 1,690 -
Cash at bank 477,041 -
662,721 182,967
CREDITORS
Amounts falling due within one year 11,634 63,400
NET CURRENT ASSETS 651,087 119,567
TOTAL ASSETS LESS CURRENT
LIABILITIES

653,738

121,320

CREDITORS
Amounts falling due after more than
one year

68,873

327,883
NET ASSETS/(LIABILITIES) 584,865 (206,563 )

BIOINDUCTION LIMITED (REGISTERED NUMBER: 04429471)

ABBREVIATED BALANCE SHEET - continued
31 MARCH 2014

31.3.14 31.3.13
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 4 3,828 2,913
Share premium 2,370,037 1,443,917
Profit and loss account (1,789,000 ) (1,653,393 )
SHAREHOLDERS' FUNDS 584,865 (206,563 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2014 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and
387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the
company as at the end of each financial year and of its profit or loss for each financial year in
accordance with the requirements of Sections 394 and 395 and which otherwise comply with
the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 17 December 2014 and were
signed on its behalf by:





I S Gillbe - Director


BIOINDUCTION LIMITED (REGISTERED NUMBER: 04429471)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2014

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in
accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery - 20% on cost
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance
for obsolete and slow moving items.

Deferred tax
Deferred tax is recognised in respect of all material timing differences that have originated
but not reversed at the balance sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of
exchange ruling at the balance sheet date. Transactions in foreign currencies are translated
into sterling at the rate of exchange ruling at the date of transaction. Exchange differences
are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to the profit and loss account in the period to which
they relate.

Going concern
The company made a loss of £135,607 (2013: £233,269) during the year, however the
financial statements have been prepared on a going concern basis as the shareholders
continue to provide the company with the necessary financial support for at least the next
twelve months.

BIOINDUCTION LIMITED (REGISTERED NUMBER: 04429471)

NOTES TO THE ABBREVIATED ACCOUNTS - continued
FOR THE YEAR ENDED 31 MARCH 2014

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2013 5,246
Additions 1,630
At 31 March 2014 6,876
DEPRECIATION
At 1 April 2013 3,548
Charge for year 732
At 31 March 2014 4,280
NET BOOK VALUE
At 31 March 2014 2,596
At 31 March 2013 1,698

3. FIXED ASSET INVESTMENTS
Investments
other
than
loans
£   
COST
At 1 April 2013
and 31 March 2014 55
NET BOOK VALUE
At 31 March 2014 55
At 31 March 2013 55

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.14 31.3.13
value: £    £   
382,801 Ordinary £0.01 3,828 2,913

91,476 Ordinary shares of £0.01 each were allotted as fully paid at a premium of £10.12419
per share during the year.

The share premium reserve increased £926,120 (2013: £122,255) following the issuance of
91,476 ordinary shares